GL1X · GenesisL1 explorer

MolNFT v1 · #86827 · protein

Crystal structures of ASK1-inhibitor complexes

4BIB · Mitogen-activated protein kinase kinase kinase 5: “Crystal structures of ASK1-inhibitor complexes”. X-ray diffraction, 1 ligand (IEO), 3 pockets (best druggability 0.66). MolNFT v1 #86827 on GenesisL1: 3D structure, binding sites…

PDB
4BIB
Type
protein
Length
512 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase kinase kinase 5
EC
2.7.11.25
UniProt
Q99683
Ligands
IEO
Pockets
3 · best druggability 0.66

Structure

x-ray diffraction · 2 distinct chains · 41% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase kinase kinase 5 (EC 2.7.11.25)protein25441% helix, 20% strandQ99683
BMitogen-activated protein kinase kinase kinase 5 (EC 2.7.11.25)protein25841% helix, 21% strandQ99683

Ligands and binding sites

  • IEO · 3-cyano-4-(piperidin-4-yloxy)-1H-indole-7-carboxamide · ligand · 2 copies · chains A, B
  • ACT · Acetate ion · additive · 3 copies · chains A, B
  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12210.660.8430IEO
22090.640.8326IEO
34350.600.7541empty

Interfaces

1 interface between chains.

  • A–B · 98 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 4BIB · Crystal Structures of Ask1-inhibitor Complexes · the same entry in another collection · chain A against A, TM-score 1.00
  • Q99683 · AlphaFold monomer V2.0 prediction for mitogen-activated protein kinase kinase kinase 5… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.